Supriya Lifescience Limited

NSE SUPRIYA.NS

Supriya Lifescience Limited Interest Coverage Ratio for the year ending March 31, 2024: 45.31

Supriya Lifescience Limited Interest Coverage Ratio is 45.31 for the year ending March 31, 2024, a 10.39% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Supriya Lifescience Limited Interest Coverage Ratio for the year ending March 31, 2023 was 41.04, a -45.44% change year over year.
Supriya Lifescience Limited Interest Coverage Ratio for the year ending March 31, 2022 was 75.22, a 79.06% change year over year.
Supriya Lifescience Limited Interest Coverage Ratio for the year ending March 31, 2021 was 42.01, a 180.53% change year over year.
Supriya Lifescience Limited Interest Coverage Ratio for the year ending March 31, 2020 was 14.97, a 128.35% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

NSE: SUPRIYA.NS

Supriya Lifescience Limited

CEO	Dr. Satish Waman Wagh
IPO Date	Dec. 28, 2021
Location	India
Headquarters	207/208 Udyog Bhavan
Employees	448
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Pet Food Tobacco

Description

Supriya Lifescience Ltd., a bulk drugs company, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, such as anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, smoking cessation, antihypertensive, and anti-malarial products, as well as vitamins, feed additives, xanthine derivatives and beverages, and phytochemicals. The company was founded in 1987 and is headquartered in Mumbai, India.

Key trends

Past 5 years